Pfizer: Levoxyl (levothyroxine Sodium Tablets, Usp), Tablets, 175 Mcg, 1000-count Bottle
Levoxyl Recall Summary Pfizer is recalling 175 mcg Levoxyl (levothyroxine sodium) tablets in 1,000-count bottles distributed nationwide and in Puerto Rico because the medication was found to be weaker than the labeled strength during stability testing. The affected product has NDC number 60793-859-10 and was made in Austria. This recall applies to all U.S. states and territories listed.
- Recalling firm
- Pfizer
- Product
- Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10
- Reason
- Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-09-29
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide and Puerto Rico
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/73e98e27-abb7-4f06-a44d-958d3f2eead4